Joel Kidman
Crawley, WA, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Comparative analysis of malignant pleural effusion and peripheral blood reveals unique T cell signatures associated with survival in mesothelioma patients.
Journal: Oxford open immunology
Published: December 10, 2024
Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockade.
Journal: Journal for immunotherapy of cancer
Published: September 08, 2024
Coupling of response biomarkers between tumor and peripheral blood in patients undergoing chemoimmunotherapy.
Journal: Cell reports. Medicine
Published: December 26, 2023
Dynamic changes in the T cell receptor repertoire during treatment with radiotherapy combined with an immune checkpoint inhibitor.
Journal: Molecular oncology
Published: May 28, 2021
Malignant Pleural Effusions-A Window Into Local Anti-Tumor T Cell Immunity?
Journal: Frontiers in oncology
Published: February 26, 2021
Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy Responses.
Journal: Frontiers in immunology
Published: July 24, 2020
Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy.
Journal: Frontiers in immunology
Published: July 17, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026